Cognition and Aging Well with Migraine
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
Key Questions
- How does migraine change over time?
- As people age and approach their 60s and 70s, can the headache part of a migraine attack start to lessen and other symptoms become more bothersome?
- How does chronic migraine evolve over time?
- Is there hope for people with chronic migraine?
- What causes late onset migraine?
- How does treatment differ for late onset migraine?
- Is it possible to take triptans over the age of 65?
- Does migraine have a cumulative effect or damage over time?
- Should we be worried about white matter lesions in an MRI scan?
- What are some concerns about taking migraine medications long term?
- Does migraine confer any risk of dementia, stroke, or heart disease?
- Is there hope for people who have migraine at an older age?
Interview Notes
- Late-life Accompaniments to Migraine and TMAs (Transient Migraine Accompaniments)
- The Diagnostic Evaluation of Secondary Headache Disorders
- Microstructural White Matter Changes Preceding White Matter Hyperintensities in Migraine
- Great Lakes Regional Headache Society
- Association of Migraine Disorders
- Shades for Migraine
- DENT Neurologic Institute
Shivang Joshi, MD, MPH, RPh
Director of Headache Medicine & Clinical Research; Assistant Professor of Neurology
Community Neuroscience Services; UMass School of Medicine
Dr. Shivang Joshi is a doctor, pharmacist, and migraine and pharmacology expert. He is board-certified in neurology and headache medicine. Dr. Joshi is the director of headache medicine and assistant professor of neurology at Community Neuroscience Services at UMass School of Medicine.
Dr. Joshi is an award-winning researcher and teacher. He is the recipient of the American Headache Society’s 2012 Frontiers in Headache Research Scholarship Award for Cluster Headache Research, and the Outstanding Teaching Award from the Albert Einstein College of Medicine.
Pre-purchase full access to the entire [YEAR] Summit, including:
Related Talks for: Day 8 (2020) Taking Control
Migraine and Psychological Comorbidities
Paul R. Martin, PhD
Navigating Insurance and Access Issues
Katie Golden
Migraine at Work: Issues and Progress
Elena Ruiz de la Torre
Telemedicine
Brian Grosberg, MD
The European Migraine & Headache Alliance is a non-profit umbrella organization, that includes over 30 patient associations for Migraine, Cluster Headache, Trigeminal Neuralgia and other headache diseases, across Europe.
VYEPTI is a new treatment for the challenges you—or someone you know—may face with this condition.
There are now over 300 items listed in this updated directory of treatments, therapies, devices, procedures, strategies and approaches to treat or prevent migraine. Only available with 2020 VIP Access Pass.
